Farmácia/Notícias da Indústria
Grandes questões sobre as doses de reforço das vacinas contra Covid-19 – “Desde o porquê até para quem, ainda precisamos de muitas respostas sobre as doses de reforço.”
17 Nov, 2021 | 13:06hThe big questions about Covid-19 booster shots – Vox
Comentário no Twitter
1/ Thoughtful piece by @voxdotcom's @germanrlopez on COVID vaccine boosters.
In good company with @ashishkjha @DrPaulOffit @MonicaGandhi9 @jenkatesdc.https://t.co/pOwZLkmJHn pic.twitter.com/ZAD7AOj0Vz
— Céline Gounder, MD, ScM, FIDSA (@celinegounder) November 12, 2021
Pílula da Pfizer contra COVID deve ser fabricada e vendida mais barata em 95 países pobres.
17 Nov, 2021 | 13:03hPfizer COVID Pill to Be Made, Sold Cheaply in 95 Poor Countries – HealthDay
Ver também:
Pfizer agrees to license generic versions of its COVID-19 pill — in some countries – NPR
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries – The New York Times (poucos artigos gratuitos por mês)
MSF responde à licença da Pfizer e do Medicines Patent Pool para o novo tratamento da Covid-19 – “O acordo, porém, cobre somente 53% da população mundial e exclui pessoas em diversos países de média renda, deixando esse medicamento promissor fora do alcance de milhões de pessoas.”
17 Nov, 2021 | 13:01h
Comentário no Twitter
Pfizer's deal w/ the Medicines Patent Pool for its COVID-19 treatment doesn't allow enough generic production & leaves this medicine out of reach for millions.
This is yet another restrictive voluntary license as cases continue to rise in many countries. https://t.co/WbVmUt9nrH
— Doctors w/o Borders (@MSF_USA) November 16, 2021
Metanálise de dados de participantes individuais nos principais estudos randomizados mostrou que o tratamento da hipertensão com inibidores da enzima conversora de angiotensina (IECA) ou bloqueadores do receptor de angiotensina (BRA) reduziu o risco de diabetes tipo 2 em comparação a outros medicamentos.
17 Nov, 2021 | 12:55hComentários:
Blood pressure drugs could prevent type 2 diabetes, study finds – The Guardian
Estudo randomizado de fase 2 | Cagrilintide 1 vez/semana é efetiva para perda de peso em pessoas com sobrepeso e obesidade.
17 Nov, 2021 | 12:51hOnce-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial – The Lancet (link para o resumo – $ para o texto completo)
Seguimento de longo prazo de estudo randomizado mostrou que bebês que receberam fórmula láctea enriquecida com suplementos ou nutrientes não apresentaram desempenho acadêmico melhor na adolescência.
17 Nov, 2021 | 12:43hComunicado de imprensa: Study finds no benefit of enriched formula milks on later academic performance – British Medical Journal
Editorial: Enriched formula milks and academic performance in later childhood – The BMJ
Comentário no Twitter
Children who are given nutrient or supplement enriched formula milk as babies do not appear to have higher exam scores as adolescents than those fed with standard formula, suggests a study published @bmj_latest today https://t.co/QmE2QxRlXm @DrMaxVerfuerden
— BMJ (@bmj_company) November 11, 2021
Hipotensão ortostática induzida por medicamentos: revisão sistemática e metanálise de estudos randomizados controlados.
17 Nov, 2021 | 12:41hRevisão | Trombocitopenia trombótica imune induzida por vacina.
16 Nov, 2021 | 12:46hVaccine-induced immune thrombotic thrombocytopenia – The Lancet Haematology
Conteúdos relacionados:
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.
Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)
Comentário no Twitter
NEW Viewpoint by @Erik_Klok_MD, @MPaiMD, Menno Huisman & @ProfMakris discussing the epidemiology, pathophysiology, and optimal diagnostic and therapeutic management of vaccine-induced immune thrombotic thrombocytopenia #VITT #COVID19Vaccine https://t.co/FI4NynwzEn pic.twitter.com/9PbjaioA2T
— The Lancet Haematology (@TheLancetHaem) November 12, 2021
Covid: Áustria impõe lockdown a não vacinados.
16 Nov, 2021 | 12:44hCovid: Austria introduces lockdown for unvaccinated – BBC
Ver também: Austria orders nationwide lockdown for the unvaccinated – Associated Press
Covid-19: produção global de vacinas é desordenada e a escassez é decorrente de outros fatores além da acumulação por alguns países.
16 Nov, 2021 | 12:43h
Comentário no Twitter
Seventy countries have yet to vaccinate 10% of their populations for covid-19. What is holding up the process?
Includes a #BMJInfographic that shows whether countries producing vaccines are able to vaccinate more of their populationshttps://t.co/9Z9BtzJKR9 pic.twitter.com/zfUfSgZQtC
— The BMJ (@bmj_latest) November 2, 2021